Chalcogenide glass-silicon hybrid waveguide and resonators for wavelength conversion
WO2015062571A1
Injectable depot formulations for the controlled release of active ingredients
EP3071019A1
Method for producing plant fibres doped with nanoparticles
DE102014012546A1
Antimycobacterially active substances, process for their preparation and their use
WO2014207573A2
Breast cancer cell growth-inhibiting enzyme inhibitors, method for the production thereof, and use thereof
WO2015003679A1
Method for biosynthesis of specific isotope-marked secondary metabolites
DE102014006502A1
Method and device for producing coated granules, pastils or tablets by means of in-situ coating
DE102014005782A1
Injectable and implantable carrier systems based on modified poly (dicarboxylic acid multiol esters) for controlled release of active ingredient
WO2014139512A1
Derivatives of indoles and carbazoles, method for the production thereof and use thereof as mrsa-sensitive antibiotics
DE102014001533A1
Process for the purification of glycerin by means of a solvent-supported layer crystallization
DE102014000856A1
Hybridoma cell line (My-C-cC0C2-259-1A4) and its use for the production of a monoclonal antibody against the human heart-specific myosin binding protein C (C-protein, MYBPC3, cMyBP-C or My-C)
DE102014000857A1
Hybridoma cell line (My-C-cC0C2-235-3H8) and its use for the production of a monoclonal antibody against the human heart-specific myosin binding protein C (C-protein, MYBPC3, cMyBP-C or My-C)
DE102011112696A1
Solar cell with film for back contact, process for its preparation and use of a film as back contact
